Prescription drug · ANDA
Bicalutamide NDC 72578-215
Bicalutamide 50 mg/1 · Tablet · Oral · Viona Pharmaceuticals Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72578-215-01 | 72578021501 | 100 TABLET in 1 BOTTLE (72578-215-01)Marketed from Jun 7, 2009 | |
| 72578-215-06 | 72578021506 | 30 TABLET in 1 BOTTLE (72578-215-06)Marketed from Jun 7, 2009 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Bicalutamide
- Generic name (nonproprietary)
- bicalutamide
- Active ingredients
- Bicalutamide — 50 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Viona Pharmaceuticals Inc.NDC labeler code 72578
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 079089
- Marketing start
- Listing expires
- Other FDA classes
- Androgen Receptor Antagonists (Mechanism)
- Identifiers
- Product ID 72578-215_7f9961d0-109d-4640-bedc-319663483652SPL ID 7f9961d0-109d-4640-bedc-319663483652SPL set ID 5a7cbe80-f119-4b3d-949a-c7824ea91908RxCUI 199123UNII A0Z3NAU9DPUPC 0372578215064, 0372578215019
- Pharmacologic class
- Androgen Receptor Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N472578021501followed by a unit qualifier and the quantityPackage 72578-0215-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Bicalutamide tablets 50 mg daily is indicated for use in combination therapy with a luteinizing hormone-releasing hormone (LHRH) analog for the treatment of Stage D 2 metastatic carcinoma of the prostate. Bicalutamide tablets 150 mg daily is not approved for use alone or with other treatments [see Clinical Studies ( 14.2 ) ]. Bicalutamide tablets 50 mg is an androgen receptor inhibitor indicated for use in combination therapy with a luteinizing hormone-releasing hormone (LHRH) analog for the treatment of Stage D 2 metastatic carcinoma of the prostate. ( 1 ) Bicalutamide tablets 150 mg daily is not approved for use alone or with other treatments ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 72578-215
- What is NDC 72578-215?
- 72578-215 is the product NDC for Bicalutamide, Bicalutamide 50 mg/1 tablet, listed with the FDA by Viona Pharmaceuticals Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Bicalutamide.
- What is the active ingredient?
- Bicalutamide.
- Who is the labeler?
- Viona Pharmaceuticals Inc., NDC labeler code 72578. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Bicalutamide?
- 8 other product NDCs are listed under this name. See all Bicalutamide NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Bicalutamide products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Bicalutamide | Bicalutamide 50 mg/1 | TabletOral | ANI Pharmaceuticals, Inc. | 62559-890 | 62559-0890-30 |
| bicalutamide | Bicalutamide 50 mg/1 | Tablet, Film coatedOral | Sun Pharmaceutical Industries, Inc. | 47335-485 | 47335-0485-0847335-0485-1847335-0485-83+1 more |
| bicalutamide | Bicalutamide 50 mg/1 | Tablet, Film coatedOral | Proficient Rx LP | 82804-082 | 82804-0082-90 |
| Bicalutamide | Bicalutamide 50 mg/1 | TabletOral | Proficient Rx LP | 71205-577 | 71205-0577-3071205-0577-6071205-0577-90 |
| Bicalutamide | Bicalutamide 50 mg/1 | TabletOral | Bryant Ranch Prepack | 63629-8308 | 63629-8308-0163629-8308-02 |
| Bicalutamide | Bicalutamide 50 mg/1 | TabletOral | Accord Healthcare Inc. | 16729-023 | 16729-0023-0116729-0023-10 |
| Bicalutamide | Bicalutamide 50 mg/1 | TabletOral | PINNACLE LIFE SCIENCE PRIVATE LIMITED | 84508-001 | 84508-0001-0184508-0001-30 |
| Bicalutamide | Bicalutamide 50 mg/1 | TabletOral | Golden State Medical Supply, Inc. | 51407-010 | 51407-0010-30 |
Other NDCs under ANDA 079089
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Bicalutamide | Bicalutamide 50 mg/1 | TabletOral | PINNACLE LIFE SCIENCE PRIVATE LIMITED | 84508-001 |